Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Gene Therapy to Target PD-L1 for Oncology by Marino Biotechnology for Breast Cancer: Likelihood of Approval
Gene Therapy to Target PD-L1 for Oncology is under clinical development by Marino Biotechnology and currently in Phase I for...
Gene Therapy to Target PD-L1 for Oncology by Marino Biotechnology for Lung Cancer: Likelihood of Approval
Gene Therapy to Target PD-L1 for Oncology is under clinical development by Marino Biotechnology and currently in Phase I for...
Gene Therapy to Target PD-L1 for Oncology by Marino Biotechnology for Colorectal Cancer: Likelihood of Approval
Gene Therapy to Target PD-L1 for Oncology is under clinical development by Marino Biotechnology and currently in Phase I for...
Gene Therapy to Target PD-L1 for Oncology by Marino Biotechnology for Lymphoma: Likelihood of Approval
Gene Therapy to Target PD-L1 for Oncology is under clinical development by Marino Biotechnology and currently in Phase I for...
Gene Therapy to Target PD-L1 for Oncology by Marino Biotechnology for Pancreatic Cancer: Likelihood of Approval
Gene Therapy to Target PD-L1 for Oncology is under clinical development by Marino Biotechnology and currently in Phase I for...
Gene Therapy to Target PD-L1 for Oncology by Marino Biotechnology for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
Gene Therapy to Target PD-L1 for Oncology is under clinical development by Marino Biotechnology and currently in Phase I for...
Gene Therapy to Target PD-L1 for Oncology by Marino Biotechnology for Metastatic Cancer: Likelihood of Approval
Gene Therapy to Target PD-L1 for Oncology is under clinical development by Marino Biotechnology and currently in Phase I for...
Gene Therapy to Target PD-L1 for Oncology by Marino Biotechnology for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
Gene Therapy to Target PD-L1 for Oncology is under clinical development by Marino Biotechnology and currently in Phase I for...